 |
 |
 |
 |
 |
 |
 |
 |
 |
Gentis, Inc.
Gentis develops synthetic products that represent fundamental improvements for treating degenerated intervertebral discs of the spine and other musculoskeletal lesions. The Company has developed a proprietary material whose unique characteristics make it ideally suited for use in the spine. In the longer-term Gentis' broad technology platform also creates a broad-based product orthobiologics pipeline.